The global Benign Prostatic Hypertrophy Implant Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to the 2022 Statistical Yearbook of the United Nations Agricultural and Food Organization, there are about 866 million people work in agriculture, accounting for more than a quarter of the world's total labor force and creating $3.6 trillion in added value. According to data, North America was the region with the most fertilizer use in the world in 2021, accounting for 32.6% of the global fertilizer market size. From the perspective of demand, the proportion of micro-fertilizers used in many European countries has reached 45-60%, and the proportion of use in the United States was as high as 60-70%. According to our 鈥淎griculture Research Center鈥�, the global fertilizer consumption was nearly 200 million tons in 2022. According to the National Bureau of Statistics, the total output value of China's fertilizer manufacturing industry in 2021 was 618.572 billion yuan, with a year-on-year increase of 5.05%. Global fertilizer consumption in 2021 increased by nearly 12 million tons, which compared to 2020.
This report aims to provide a comprehensive presentation of the global market for Benign Prostatic Hypertrophy Implant Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Benign Prostatic Hypertrophy Implant Devices.
Report Scope
The Benign Prostatic Hypertrophy Implant Devices market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Benign Prostatic Hypertrophy Implant Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Benign Prostatic Hypertrophy Implant Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Olympus Medical
Butterfly Medical
SRS Medical
Teleflex Interventional Urology
Urotronic
Zenflow
ProArc Medical
Medeon Biodesign
Segment by Type
Temporary
Long-term
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Benign Prostatic Hypertrophy Implant Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Benign Prostatic Hypertrophy Implant Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Benign Prostatic Hypertrophy Implant Devices Market Overview
1.1 Product Overview and Scope of Benign Prostatic Hypertrophy Implant Devices
1.2 Benign Prostatic Hypertrophy Implant Devices Segment by Type
1.2.1 Global Benign Prostatic Hypertrophy Implant Devices Market Value Comparison by Type (2024-2030)
1.2.2 Temporary
1.2.3 Long-term
1.3 Benign Prostatic Hypertrophy Implant Devices Segment by Application
1.3.1 Global Benign Prostatic Hypertrophy Implant Devices Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Benign Prostatic Hypertrophy Implant Devices Market Size Estimates and Forecasts
1.4.1 Global Benign Prostatic Hypertrophy Implant Devices Revenue 2019-2030
1.4.2 Global Benign Prostatic Hypertrophy Implant Devices Sales 2019-2030
1.4.3 Global Benign Prostatic Hypertrophy Implant Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Benign Prostatic Hypertrophy Implant Devices Market Competition by Manufacturers
2.1 Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Benign Prostatic Hypertrophy Implant Devices Average Price by Manufacturers (2019-2024)
2.4 Global Benign Prostatic Hypertrophy Implant Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Benign Prostatic Hypertrophy Implant Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Benign Prostatic Hypertrophy Implant Devices, Product Type & Application
2.7 Benign Prostatic Hypertrophy Implant Devices Market Competitive Situation and Trends
2.7.1 Benign Prostatic Hypertrophy Implant Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Benign Prostatic Hypertrophy Implant Devices Players Market Share by Revenue
2.7.3 Global Benign Prostatic Hypertrophy Implant Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Benign Prostatic Hypertrophy Implant Devices Retrospective Market Scenario by Region
3.1 Global Benign Prostatic Hypertrophy Implant Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Benign Prostatic Hypertrophy Implant Devices Global Benign Prostatic Hypertrophy Implant Devices Sales by Region: 2019-2030
3.2.1 Global Benign Prostatic Hypertrophy Implant Devices Sales by Region: 2019-2024
3.2.2 Global Benign Prostatic Hypertrophy Implant Devices Sales by Region: 2025-2030
3.3 Global Benign Prostatic Hypertrophy Implant Devices Global Benign Prostatic Hypertrophy Implant Devices Revenue by Region: 2019-2030
3.3.1 Global Benign Prostatic Hypertrophy Implant Devices Revenue by Region: 2019-2024
3.3.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue by Region: 2025-2030
3.4 North America Benign Prostatic Hypertrophy Implant Devices Market Facts & Figures by Country
3.4.1 North America Benign Prostatic Hypertrophy Implant Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Benign Prostatic Hypertrophy Implant Devices Sales by Country (2019-2030)
3.4.3 North America Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Benign Prostatic Hypertrophy Implant Devices Market Facts & Figures by Country
3.5.1 Europe Benign Prostatic Hypertrophy Implant Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Benign Prostatic Hypertrophy Implant Devices Sales by Country (2019-2030)
3.5.3 Europe Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Benign Prostatic Hypertrophy Implant Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Benign Prostatic Hypertrophy Implant Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Benign Prostatic Hypertrophy Implant Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Benign Prostatic Hypertrophy Implant Devices Market Facts & Figures by Country
3.7.1 Latin America Benign Prostatic Hypertrophy Implant Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Benign Prostatic Hypertrophy Implant Devices Sales by Country (2019-2030)
3.7.3 Latin America Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Benign Prostatic Hypertrophy Implant Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Benign Prostatic Hypertrophy Implant Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Benign Prostatic Hypertrophy Implant Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Benign Prostatic Hypertrophy Implant Devices Sales by Type (2019-2030)
4.1.1 Global Benign Prostatic Hypertrophy Implant Devices Sales by Type (2019-2024)
4.1.2 Global Benign Prostatic Hypertrophy Implant Devices Sales by Type (2025-2030)
4.1.3 Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type (2019-2030)
4.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue by Type (2019-2030)
4.2.1 Global Benign Prostatic Hypertrophy Implant Devices Revenue by Type (2019-2024)
4.2.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue by Type (2025-2030)
4.2.3 Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Type (2019-2030)
4.3 Global Benign Prostatic Hypertrophy Implant Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Benign Prostatic Hypertrophy Implant Devices Sales by Application (2019-2030)
5.1.1 Global Benign Prostatic Hypertrophy Implant Devices Sales by Application (2019-2024)
5.1.2 Global Benign Prostatic Hypertrophy Implant Devices Sales by Application (2025-2030)
5.1.3 Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application (2019-2030)
5.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue by Application (2019-2030)
5.2.1 Global Benign Prostatic Hypertrophy Implant Devices Revenue by Application (2019-2024)
5.2.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue by Application (2025-2030)
5.2.3 Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Application (2019-2030)
5.3 Global Benign Prostatic Hypertrophy Implant Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Olympus Medical
6.1.1 Olympus Medical Corporation Information
6.1.2 Olympus Medical Description and Business Overview
6.1.3 Olympus Medical Benign Prostatic Hypertrophy Implant Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Olympus Medical Benign Prostatic Hypertrophy Implant Devices Product Portfolio
6.1.5 Olympus Medical Recent Developments/Updates
6.2 Butterfly Medical
6.2.1 Butterfly Medical Corporation Information
6.2.2 Butterfly Medical Description and Business Overview
6.2.3 Butterfly Medical Benign Prostatic Hypertrophy Implant Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Butterfly Medical Benign Prostatic Hypertrophy Implant Devices Product Portfolio
6.2.5 Butterfly Medical Recent Developments/Updates
6.3 SRS Medical
6.3.1 SRS Medical Corporation Information
6.3.2 SRS Medical Description and Business Overview
6.3.3 SRS Medical Benign Prostatic Hypertrophy Implant Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 SRS Medical Benign Prostatic Hypertrophy Implant Devices Product Portfolio
6.3.5 SRS Medical Recent Developments/Updates
6.4 Teleflex Interventional Urology
6.4.1 Teleflex Interventional Urology Corporation Information
6.4.2 Teleflex Interventional Urology Description and Business Overview
6.4.3 Teleflex Interventional Urology Benign Prostatic Hypertrophy Implant Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teleflex Interventional Urology Benign Prostatic Hypertrophy Implant Devices Product Portfolio
6.4.5 Teleflex Interventional Urology Recent Developments/Updates
6.5 Urotronic
6.5.1 Urotronic Corporation Information
6.5.2 Urotronic Description and Business Overview
6.5.3 Urotronic Benign Prostatic Hypertrophy Implant Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Urotronic Benign Prostatic Hypertrophy Implant Devices Product Portfolio
6.5.5 Urotronic Recent Developments/Updates
6.6 Zenflow
6.6.1 Zenflow Corporation Information
6.6.2 Zenflow Description and Business Overview
6.6.3 Zenflow Benign Prostatic Hypertrophy Implant Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Zenflow Benign Prostatic Hypertrophy Implant Devices Product Portfolio
6.6.5 Zenflow Recent Developments/Updates
6.7 ProArc Medical
6.6.1 ProArc Medical Corporation Information
6.6.2 ProArc Medical Description and Business Overview
6.6.3 ProArc Medical Benign Prostatic Hypertrophy Implant Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ProArc Medical Benign Prostatic Hypertrophy Implant Devices Product Portfolio
6.7.5 ProArc Medical Recent Developments/Updates
6.8 Medeon Biodesign
6.8.1 Medeon Biodesign Corporation Information
6.8.2 Medeon Biodesign Description and Business Overview
6.8.3 Medeon Biodesign Benign Prostatic Hypertrophy Implant Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Medeon Biodesign Benign Prostatic Hypertrophy Implant Devices Product Portfolio
6.8.5 Medeon Biodesign Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Benign Prostatic Hypertrophy Implant Devices Industry Chain Analysis
7.2 Benign Prostatic Hypertrophy Implant Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Benign Prostatic Hypertrophy Implant Devices Production Mode & Process
7.4 Benign Prostatic Hypertrophy Implant Devices Sales and Marketing
7.4.1 Benign Prostatic Hypertrophy Implant Devices Sales Channels
7.4.2 Benign Prostatic Hypertrophy Implant Devices Distributors
7.5 Benign Prostatic Hypertrophy Implant Devices Customers
8 Benign Prostatic Hypertrophy Implant Devices Market Dynamics
8.1 Benign Prostatic Hypertrophy Implant Devices Industry Trends
8.2 Benign Prostatic Hypertrophy Implant Devices Market Drivers
8.3 Benign Prostatic Hypertrophy Implant Devices Market Challenges
8.4 Benign Prostatic Hypertrophy Implant Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Olympus Medical
Butterfly Medical
SRS Medical
Teleflex Interventional Urology
Urotronic
Zenflow
ProArc Medical
Medeon Biodesign
听
听
*If Applicable.
